SYNTARA LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.016 AUD | -11.11% |
|
-5.88% | -20.00% |
| 04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
| 04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.0180 | 0.0220 | 0.0290 |
| Spread/Res. | -11.11% | -27.27% | -44.83% |
| Spread/Supp. | +6.67% | +6.67% | +6.67% |
| Support | 0.0150 | 0.0150 | 0.0150 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SNT Stock
- Charts Syntara Limited